Selvakumar Ramalingam

Title: Selvakumar Ramalingam: Innovator in Transdermal Drug Delivery

Introduction

Selvakumar Ramalingam is a notable inventor based in Tamil Nadu, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of transdermal drug delivery systems. His innovative approach has led to the creation of a unique formulation that enhances the efficacy of dexibuprofen.

Latest Patents

Selvakumar holds a patent for the "Composition of dexibuprofen transdermal hydrogel." This stable non-alcoholic transdermal hydrogel was prepared using a simple manufacturing process. Experimental trials indicated that the pH modifying agent, antioxidant, and water miscible solvent are essential excipients for obtaining a stable formulation. The dexibuprofen hydrogel prepared with carbopol as a gelling polymer resulted in an opaque gel, while the hydrogel made with hydroxypropyl methylcellulose (HPMC) produced a transparent gel. Stability studies conducted at accelerated conditions (40°C/75% RH) for three months in laminated tubes showed no significant changes in physical description, pH, assay, or related substance values.

Career Highlights

Throughout his career, Selvakumar has worked with reputable companies such as Strides Shasun Limited and Strides Pharma Science Limited. His experience in these organizations has contributed to his expertise in pharmaceutical formulations and drug delivery systems.

Collaborations

Some of Selvakumar's notable coworkers include Jeffrey Stuart Bergman and Sampathkumar Devarajan. Their collaboration has likely fostered an environment of innovation and shared knowledge in the field of pharmaceuticals.

Conclusion

Selvakumar Ramalingam's contributions to transdermal drug delivery systems exemplify his commitment to innovation in the pharmaceutical industry. His patent for the dexibuprofen transdermal hydrogel showcases his ability to develop effective and stable formulations.